Healthcare provider profile · identity verified

Snigdha Volety, MD

Family Practice · ROCKFORD, IL · NPI 1821283565

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	170
Levothyroxine Sodium	Levothyroxine Sodium	584	153
Amlodipine Besylate	Amlodipine Besylate	475	139
Lisinopril	Lisinopril	374	109
Carvedilol	Carvedilol	300	84
Metoprolol Succinate	Metoprolol Succinate	246	74
Omeprazole	Omeprazole	214	65
Hydrochlorothiazide	Hydrochlorothiazide	211	68
Pravastatin Sodium	Pravastatin Sodium	185	52
Losartan Potassium	Losartan Potassium	176	54
Metformin Hcl Er	Metformin Hcl	131	47
Glipizide Er	Glipizide	124	35
Ozempic	Semaglutide	119	18
Alendronate Sodium	Alendronate Sodium	118	42
Pantoprazole Sodium	Pantoprazole Sodium	116	41
Gabapentin	Gabapentin	113	36
Metformin Hcl	Metformin Hcl	111	35
Simvastatin	Simvastatin	110	36
Rosuvastatin Calcium	Rosuvastatin Calcium	107	31
Tramadol Hcl	Tramadol Hcl	100	33
Duloxetine Hcl	Duloxetine Hcl	98	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	97	27
Fluoxetine Hcl	Fluoxetine Hcl	96	29
Albuterol Sulfate Hfa	Albuterol Sulfate	92	30
Eliquis	Apixaban	91	15
Potassium Chloride	Potassium Chloride	84	29
Metoprolol Tartrate	Metoprolol Tartrate	78	30
Fenofibrate	Fenofibrate,micronized	70	15
Jardiance	Empagliflozin	69	26
Sertraline Hcl	Sertraline Hcl	69	17
Prednisone	Prednisone	66	38
Allopurinol	Allopurinol	63	17
Meloxicam	Meloxicam	62	20
Trazodone Hcl	Trazodone Hcl	60	17
Escitalopram Oxalate	Escitalopram Oxalate	58	22
Furosemide	Furosemide	58	23
Gemfibrozil	Gemfibrozil	58	21
Ezetimibe	Ezetimibe	57	14
Lovastatin	Lovastatin	55	14
Zolpidem Tartrate	Zolpidem Tartrate	55	12
Alprazolam	Alprazolam	54	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	24
Famotidine	Famotidine	49	14
Mirtazapine	Mirtazapine	49	13
Tamsulosin Hcl	Tamsulosin Hcl	48	17
Warfarin Sodium	Warfarin Sodium	46	16
Xarelto	Rivaroxaban	46	12
Fluticasone Propionate	Fluticasone Propionate	45	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Klor-Con M20	Potassium Chloride	41	22
Hydroxyzine Hcl	Hydroxyzine Hcl	40	13
Atenolol	Atenolol	39	11
Chlorthalidone	Chlorthalidone	37	12
Clopidogrel	Clopidogrel Bisulfate	36	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	12
Trulicity	Dulaglutide	36	suppressed
Azithromycin	Azithromycin	35	28
Mounjaro	Tirzepatide	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	12
Amoxicillin	Amoxicillin	32	28
Nystatin	Nystatin	32	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	12
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Clonazepam	Clonazepam	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Hydrocortisone	Hydrocortisone	24	16
Levofloxacin	Levofloxacin	24	16
Mupirocin	Mupirocin	24	22
Pregabalin	Pregabalin	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ibuprofen	Ibuprofen	22	15
Irbesartan	Irbesartan	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	21	suppressed
Folic Acid	Folic Acid	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	12
Torsemide	Torsemide	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Memantine Hcl	Memantine Hcl	19	suppressed
Minoxidil	Minoxidil	19	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Farxiga	Dapagliflozin Propanediol	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Penicillin V Potassium	Penicillin V Potassium	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Glipizide	Glipizide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Cephalexin	Cephalexin	12	12
Fluconazole	Fluconazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error